Elanco Animal Health Inc

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

ELAN$26.76-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	September 30, 2024	December 31, 2023
(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$490	$352
Accounts receivable, net	840	842
Other receivables	64	168
Inventories	1,632	1,735
Prepaid expenses and other	340	310
Total current assets	3,366	3,407
Noncurrent Assets
Goodwill	4,625	5,094
Other intangibles, net	4,011	4,494
Other noncurrent assets	302	341
Property and equipment, net	979	1,026
Total assets	$13,283	$14,362
Liabilities and Equity
Current Liabilities
Accounts payable	$259	$270
Sales rebates and discounts	333	367
Current portion of long-term debt	44	38
Other current liabilities	685	566
Total current liabilities	1,321	1,241
Noncurrent Liabilities
Long-term debt	4,313	5,736
Deferred taxes	539	567
Other noncurrent liabilities	587	595
Total liabilities	6,760	8,139
Commitments and Contingencies
Equity
Common stock, no par value, 5,000,000,000 shares authorized, 494,333,072 and 492,845,216 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	—	—
Additional paid-in capital	8,804	8,777
Accumulated deficit	(1,942)	(2,288)
Accumulated other comprehensive loss	(339)	(266)
Total equity	6,523	6,223
Total liabilities and equity	$13,283	$14,362

2024 Q3 Form 10-Q | 6

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.